M eniere's disease, or idiopathic endolymphatic. Intratympanic Gentamicin Treatment : Preliminary Results in Two Patients with Meniere's Disease
|
|
- Lorin Quinn
- 6 years ago
- Views:
Transcription
1 J Am Acad Audiol 6 : (1995) Intratympanic Gentamicin Treatment : Preliminary esults in Two Patients with Meniere's Disease Mary Beth Trine* Susan G. ynn* George W Facert Jan. Kasperbauert Abstract Meniere's disease is a vestibular disturbance characterized by episodic vertigo, tinnitus, and fluctuant hearing loss. The long-term effectiveness of available medical and nonablative surgical treatments has been variable, with frequent symptom recurrence. Vestibular neurectomy and labyrinthectomy, surgically ablative techniques, provide more permanent relief from vertiginous attacks. However, these procedures pose possible morbidity and cochlear risk. In this paper, preliminary results are presented for two patients who underwent intratympanic gentamicin application. ike surgical labyrinthectomy, intratympanic use of gentamicin is intended as an ablative procedure, but with potentially less risk to hearing. More vestibulotoxic than cochleotoxic, gentamicin initially disrupts the endolymph-secreting vestibular dark cells, thereby preventing endolymphatic hydrops development. Following gentamicin application, both patients demonstrated a significant change in peripheral vestibular function, as characterized by a reduction of caloric response, impaired posturography performance, and reduced low-frequency gain on rotary chair testing. Posturography performance subsequently improved, confirming functional compensation. Both patients reported relief from vertiginous attacks. However, word recognition ability was significantly worse in one of these two patients. Changes in pure-tone thresholds were minimal. Key Words : Aminoglycoside, cochlear hydrops, endolymphatic hydrops, gentamicin, intratympanic gentamicin application, Meniere's disease M eniere's disease, or idiopathic endolymphatic hydrops, is characterized by episodes of vertigo, tinnitus, aural fullness, and fluctuant hearing loss. The hearing loss is typically low frequency and sensorineural, although a flat configuration may be demonstrated. Documentation of hearing fluctuations helps to confirm the diagnosis. Caloric testing may or may not demonstrate a unilateral weakness. There are many different types of medical and surgical treatments for Meniere's disease. An incomplete list includes labyrinthectomy, 'Section of Audiology, Vestibular Testing, Department of Otorhinolaryngology, Mayo Clinic, ochester, Minnesota ; tdepartment of Otorhinolaryngology, Mayo Clinic, ochester, Minnesota eprint requests : Mary Beth Trine, Mayo Clinic, Eisenberg 3-F, 200 First Street, SW, ochester, MN vestibular neurectomy, sacculotomy, endolymphatic shunt, medications (Antivert, Meclizine, Valium), low salt diet, vestibular rehabilitation, and ototoxic agents. Unfortunately, the longterm effectiveness of most of these treatments has been variable (uckenstein et al, 1991). Nonablative surgeries and medical treatment are frequently followed by the recurrence of symptoms. Documentation of treatment effectiveness is also complicated by the unpredictable remissions and exacerbations that characterize Meniere's disease and by the strong placebo effect that has been demonstrated in this population (Torok, 1977 ; uckenstein et al, 1991). Only the ablative surgeries, such as labyrinthectomy and vestibular neurectomy, have been reliably effective, offering control of vertigo in over 90 percent of cases followed for a 5-year period (uckenstein et al, 1991). A recently popularized treatment involves a reduction of vestibular functioning in the 264
2 Gentamicin 'Ireatment/1Yine et al affected ear with the use of ototoxic medications. The use of transtympanic streptomycin therapy was first described by Schuknecht in A similar technique using gentamicin was described in 1978 by Arslan and also by Beck. A review of recent literature indicates that relief from vertiginous symptoms with intratympanic gentamicin use is achieved in 66 percent to 90 percent of reported cases (Beck, 1986 ; aitakari, 1990 ; Nedzelski et al, 1992, 1993). The preservation of residual hearing ranges from 56 percent to 85 percent, with some authors reporting improvements in pure-tone averages and on word recognition testing. esearch indicates that gentamicin is more vestibulotoxic than cochleotoxic (Bagger-Sjoback et al, 1990 ; Magnusson and Padoan, 1991). As such, its intended role in the treatment of Meniere's disease is to provide relief from vertigo while sparing residual hearing. Gentamicin reduces vestibular function by initially affecting the secretory epithelia of the vestibular labyrinth, the dark cells (Beck, 1986 ; Bagger- Sjoback et al, 1990 ; aitakari, 1990 ; Nedzelski et al, 1992, 1993). ocated in the cristae ampullae of the semicircular canals, the vestibular dark cells are responsible for the secretion of endolymph. Intratympanic gentamicin application is, then, an ablative procedure that is intended to selectively damage vestibular secretory dark cells, thereby preventing the development of endolymphatic hydrops. Compared to surgical labyrinthectomy, there is less risk to the overall well-being of the patient and to the cochlea. We have recently had experience with this procedure in two patients with long-standing diagnoses of Meniere's disease. Two cubic centimeters (80 mg) of IV gentamicin were injected into the middle ear cavity of the symptomatic ear. A single injection was provided, with the intent of further injections should vertiginous symptoms persist. This procedure was completed on an outpatient basis. In each case, use of intratympanic gentamicin was intended to reduce vertiginous symptoms and to preserve residual hearing. A METHOD udiometric testing was performed pre- and post-gentamicin treatment. This included pure-tone air- and bone-conduction and word recognition testing (CID W-22 word lists). Vestibular assessment, including electronystagmography (ENG) and computerized dynamic posturography, was also completed prior to gentamicin use and twice after the intratympanic injection. A caloric interear difference of >_ 20 percent constituted a peripheral vestibular deficit for the ear with the weaker caloric response. Directional preponderance was significant if 30 percent. otary chair testing was included during the follow-up evaluations. Patient A CASE EPOT Patient A was diagnosed with left ear endolymphatic hydrops possibly secondary to labyrinthine otosclerosis in 1980 at the age of 32. Initial symptoms included left ear tinnitus, fluctuating left ear hearing loss, and vertigo with nausea and vomiting. Typical episodes persisted from 1 to 2 hours. Hearing testing revealed a severe rising to mild sensorineural hearing loss in the left ear. See Table 1 for documentation of pure-tone threshold measurements and word recognition testing. Patient A also reported visual blurring and difficulties with gait and hand-eye coordination. His gait was described as ataxic. Antivert provided minimal control of the vertigo. Sodium fluoride was prescribed to treat the otosclerosis. A neurologic examination was negative. The severity and duration of vertiginous attacks increased in 1981, with episodes persisting from 4 hours to 3 days. eft ear tinnitus and hearing fluctuations continued. Audiometric testing on May 5, 1981 revealed a relatively flat, moderate sensorineural hearing loss in the left ear. A left ear Cody tack sacculotomy was performed in July 1981(Cody, 1969, 1973 ; Cody and McDonald, 1983). Following surgery, patient A experienced no vertigo until 1991, 10 years later. However, onset of right ear aural fullness and tinnitus was reported in Table 1 documents minor fluctuations in right ear hearing. With recurrence of the vertigo, patient A also experienced unsteadiness and loudness discomfort. A tentative diagnosis of early right ear hydrops was made. In 1992, he reported continued episodes of vertigo with nausea and vomiting, right ear hearing fluctuations, and increased right ear tinnitus. Audiometric testing documented a mild, low-frequency sensorineural hearing loss in the right ear (see Table 1). Bilateral endolymphatic hydrops was diagnosed, and a course of prednisone was prescribed in an effort to improve
3 Journal of the American Academy of Audiology/Volume 6, Number 3, May 1995 Table 1 Pure-tone Air-conduction Thresholds (db H) and Word ecognition Scores for Patient A Frequency (Hz) Date Word e cognition % / db S 6/24/ /26 (a) 72 / 26 (b) 88 / 40 5/5/ /25 (a) 72 / 25 (b) 68 / 40 8/5/ Not tested 16/20 5/19/ /40 8/25 10/16/ /25 12/25 5/8/ /40 32/25 * 12/30/ /40 28/25 13/10/ /40 24/25 Note: hearing losses are sensorineural. *re-gentamicin hearing assessment, tpost-gentamicin hearing assessment. = right ; = left. r sups. tat POST-TnEAT NEN7 PATIENT A IN POST.TXATMNT ENG Subhate rw~w ENG Subl1W V 81dnp. Eyaapa -- GM TOW ~ S.": EY..pen rt %a b Ey..dia.o e ~ N a 0 VS,0-b N.Wi a n mob'"0-6 N. 6.a-h.r10`9 30`"9- 'm r) right ear hearing. Use of a transdermal scopolamine patch provided some relief, minimizing the severity of the vertigo. Patient A returned in December 1993 reporting progression of right ear hearing loss, right ear tinnitus, loudness discomfort, and continued episodes of vertigo that persisted from 2 to 3 hours. Hearing testing revealed a moderate, lowfrequency as.upro wa sensorineural hearing loss with normal thresholds at 2000 to 4000 Hz in the right ear ; word recognition was 96 percent. Vestibular assessment documented a peripheral vestibular PATIENT A PATIENT A PE-TlEATa4NT Who : Eyp 17.3H E.a ow dm.. ENG Subl.t. G- Td 'a7"" l clue T" Eya down y Supra J~ HsaO-rigM 3D'aupht.,Vas r Glob Tap In ipln 0001 Iad-Aphl ca Supra Cal0bTest far ) ipe toed of.1. tlll iywarm E3 "r. to 0-.N cool _q v. 95.nw.rr~ Io -/a _U uw W xdlh~ wabwes Dp % ran- ~- prpad.gno. -Z v5 ight warm 5- "ra AB 0-.n cool C 'n -.tt.aa 11- 'la UW '-- %nitl.rwo DP XdWnnw Equ&=S=e weakness on the left, normal posturography, and abnormal phase at 0.01 Hz on rotary chair testing (Fig. 1). Based on the frequency and severity of his symptoms, patient A underwent an intratympanic gentamicin injection under local anesthesia on December 30, With the use of a spinal needle, 2 cc (80 mg) of IV gentamicin were injected into the right middle ear space. The patient remained supine with the head angle to the left for 45 minutes. Patient Areturned to the clinic on February 3, 1994, 5 weeks after the gentamicin injection, C wabw W".Wrtroa Cal- Tnt(rr waw) ipe cm _ us ipe- N -n 1A.Ncoa hot 'n -.n wrm Io 'r. UW SS' 70- whop 91 %*Mar- I=r vs 6 a rs ~ D pwpawanrna Figure l Patient A pre- and post-treatment ENG/posturography results. Note that the intense latent nystagmus recorded during the first post-treatment ENG improved significantly by the second post-treatment evaluation. 266
4 Gentamicin 'IYeatment/TYine et al for follow-up assessment. At that time, he described oscillopsia, imbalance, and one episode of vertigo with nausea and vomiting. He stated that the vertigo occurred on February 2, 1994 and persisted for approximately 1 hour. Patient A described the vertigo as a "swinging pendulum," rather than a spinning, sensation. He emphasized that this episode was less intense and of less duration than previous episodes. He declined audiometric testing, reporting no noticeable change in hearing. ENG assessment demonstrated a left-beating latent nystagmus, a significant left-beating directional preponderance, and a borderline peripheral vestibular weakness bilaterally (see Fig. 1). Posturography revealed a vestibular deficit pattern ; falls occurred on all trials of subtests 5 and 6. otary chair testing produced borderline gain at 0.01 through 0.04 Hz. Abnormal low-frequency gain measurements confirmed a bilateral peripheral vestibular deficit with residual function at higher frequencies of stimulation. A bilateral weakness was consistent with the patient's report of oscillopsia. Based on post-gentamicin changes in posturography performance (onset of a vestibular deficit pattern) and on the patient's complaints of imbalance, he was referred to physical therapy for vestibular rehabilitation. A second post-gentamicin vestibular assessment was completed 1 month later, on March 10, Patient A reported continued fluctuations in right ear hearing but noted that right ear tinnitus, although still present, was "less bothersome." He stated that there had been no vertigo since February 2, Patient A reported improved balance and resolution of the oscillopsia. He attributed these improvements to the vestibular rehabilitation exercises. ENG testing revealed a peripheral vestibular weakness on the left, a left-beating directional preponderance, and a left-beating latent nystagmus (see Fig. 1). Posturography was normal, suggesting that functional compensation had occurred. Improved posturography performance was consistent with the patient's report of improved balance. otary chair was similar to pre-gentamicin testing ; phase was abnormal at 0.01 Hz. ight ear audiometric testing revealed a moderate, low-frequency sensorineural hearing loss rising to normal thresholds at 1500 through 4000 Hz and a word recognition score of 96 percent. A 15-dB threshold improvement was demonstrated at 1000 Hz, while a 15-dB threshold decrement was seen at 8000 Hz. Patient B CASE EPOT Patient B was diagnosed with left ear Meniere's disease in April 1979, at age 52. At that time, he reported a 2-year history of episodic vertigo with nausea and vomiting, fluctuating left ear hearing, left ear tinnitus, and loudness discomfort. Audiometric testing revealed moderate low-frequency hearing impairment with normal hearing thresholds at 2000 and 3000 Hz in the left ear (Table 2). Serologic tests and neurologic Table 2 Pure-tone Air-conduction Thresholds (db H) and Word ecognition Scores for Patient B Frequency (Hz) Date Word ecognition % / db S 4/26/ /26 (a) 60 / 26 (b) 64 / 40 1/3/ /25 (a) 76 / 25 (b) 84 / 40 6/11/ /40 (a) 24 / 25 (b) 56 / 40 6/22/ /40 (a) 20 / 25 (b) 44 / 40 7/14/ /40 (a) 32 / 25 (b) 68 / 40 4/5/ /25 (a) 32 / 25 (b) 52 / 40 '12/8/ /40 (a) 52 / 25 (b) 56 / 40 13/1/ /40 (a) 28 / 25 (b) 24 / 25 Note : hearing losses are sensorineural. `Pre-gentamicin hearing assessment ; tpost-gentamicin hearing assessment. = right ; = left. (repeated)
5 Journal of the American Academy of Audiology/Volume 6, Number 3, May 1995 assessment were negative. A low salt diet was recommended, and ipoflavinoid was prescribed. In 1983, patient B described continued episodes of intermittent vertigo. However, the duration of these attacks had increased, with one episode lasting 4 days. He noted progression of the left ear hearing loss and continued left ear tinnitus and aural fullness. Hearing testing demonstrated changes in left ear hearing, with poorer low-frequency thresholds (see Table 2). He returned to the clinic on June 11, 1992 with roaring right ear tinnitus, sudden right ear hearing loss, and imbalance. Pure-tone testing revealed an arched audiometric configuration in the right ear. Hearing sensitivity in this ear had previously been normal through 3000 Hz. ight ear labyrinthitis (versus hydrops) was diagnosed, with "old Meniere's left, inactive." A course of prednisone was prescribed in an effort to restore right ear hearing thresholds. Two weeks later, on June 22, 1992, audiometric testing demonstrated a mild sloping to moderately severe sensorineural hearing loss in this ear. Prednisone was discontinued in July 1992 subsequent to patient complaints of agitation. At that time, the diagnosis was changed to right ear hydropssuspected. In April 1993, patient B reported recurrence of tinnitus and occasional loss of balance. He denied vertigo. Pure-tone testing documented continued fluctuations in low-frequency right ear hearing sensitivity (see Table 2) and a word recognition score of 80 percent. Patient B returned to the clinic on December 8, 1993, describing daily attacks of vertigo with nausea and vomiting. Episodes persisted from 20 to 60 minutes, with resolution of imbalance between attacks. Patient B had been vertigo-free since He stated that previously experienced tinnitus had ceased. ENT notes documented no localizing ear symptoms. Audiometric testing revealed minimal changes in hearing thresholds. The diagnosis was defined as "hydrops suspect right, old Meniere's left." Patient B presented 2 weeks later on December 22, 1993 describing daily episodes of vertigo that were accompanied by increases in left ear aural fullness and tinnitus. Vestibular assessment on January 13, 1994 revealed a mild, peripheral vestibular weakness on the left (24% interear difference) and normal posturography (Fig. 2). An MI was negative. The patient was diagnosed with left endolymphatic hydrops. Based on the daily occurrence of vertigo, an intratympanic gentamicin procedure was completed on January 18, Two cubic centimeters (80 mg) of IV gentamicin were injected into the left middle ear. Patient B returned to the clinic on February 1, 1994, 2 weeks after the intratympanic injection, for follow-up. He complained of persistent imbalance, increased left ear tinnitus, and left ear deafness. He denied vertigo. Vestibular assessment revealed a severe, peripheral vestibular weakness on the left (78% interear difference), a rightbeating directional preponderance, a borderline vestibular deficit pattern on posturography, and PATIENT PA T E NT T PEi-171ATMENT PATIENT IN P C1 EATMENT POST"T1ATMENT 11-N ENG SubK.b EKG Sublwb ENG Suble.b x n r Nw.a (c. Twt.w~ rom. Gin T..1 ~- SOW E"..W V Gs Tom ~_ SIIhP: Eyro. upm ~ SNnp : Eyw qan - Eyw d-d Ey-d.-d V EywdwM r 810" SUPM y H..6IgM.1 SipYW H..7'pld INW MM HNidIM ~_ H..?YII J H..d-bll -~ax H.W11rg.q IU IMW-Iwq~O J Hw6M.Wg.! 30". r wp. ar ~ 30" Up- - Cdaic T.N (.if yyl) C.bdc T.N Y1 C.bdcTwtIw w. g M PP W /O "I. ~ - NoM-1 IS -IS e- - ghcw JJ_ h ~Z 6~ l W y. wm ~ a ~ _ fpmwe.m "h ~ lall mn ~ h 1 ~~ loll N f h omwum 4j "h J". = - t,. c.d.hm _. h ~ l e wrm _ N "h OW ~_ %dwmnw.. wvm. "w "h UW 7P %ddm.rn UW ZZ %dff- DP 14 %M~ w.no,.w DP 44 %oonna wwd~d~.~. DP st % M~ ".d.- Figure 2 Patient B pre- and post-treatment ENG/posturography results. 268
6 Gentamicin Treatmentfrrine et al abnormal gain at 0.01 through 0.16 Hz on rotary chair testing (see Fig. 2). Audiometric testing was not completed, and as per ENT notes, referral to vestibular rehabilitation was delayed for 1 month. A second post-gentamicin assessment was completed on March 1, 1994, 6 weeks posttreatment. Patient B reported that his equilibrium was gradually improving. Imbalance remained noticeable but was less severe than that experienced in the days immediately following the gentamicin injection. He denied vertigo. He described a reduction in the intensity of left ear tinnitus ; however, he continued to report left ear deafness. Hearing testing revealed a relatively flat, moderately severe to severe sensorineural hearing loss in the left ear and word recognition scores of 28 percent and 24 percent for repeated testing at 25 db S (see Table 2). A 20-dB threshold decrement was noted at 2000 Hz. Compared to testing in December 1993, word recognition ability was significantly poorer ; previous scores were 52 percent and 56 percent at 25 and 40 db S, respectively. Vestibular assessment revealed a peripheral vestibular weakness on the left (87% interear difference), no significant latent nystagmus, abnormal gain at 0.01 through 0.04 Hz on rotary chair testing, and normal posturography performance (see Fig. 2). Due to the patient's complaints of continued imbalance, vestibular rehabilitation was offered. Patient B declined rehabilitation at that time, noting that he would soon undergo minor orthopedic surgery. B DISCUSSION oth of the patients presented in this paper experienced severe and frequent episodes of vertigo that interfered with professional and social activities. Both presented with a diagnosis of Meniere's disease, or idiopathic endolymphatic hydrops, and with a history of symptoms that had persisted for more than 12 years. Following a 2 cc (80 mg) intratympanic injection of IV gentamicin, both patients demonstrated a significant change in peripheral vestibular function, as measured by caloric testing. Changes in the caloric response suggest that disruption of the sensory epithelium, in addition to the vestibular dark cells, was involved. Patient A demonstrated a slightly stronger caloric response in the gentamicin ear at the second follow-up vestibular assessment. This finding may indicate a recovery of sensory function ; possibly, cells were impaired following ototoxic exposure, but damage was not permanent. Post-treatment performance on posturography produced a definite or borderline vestibular deficit pattern in both patients. This pattern was consistent with patient complaints of imbalance following gentamicin application. However, repetition of posturography testing at the second follow-up documented improved balance, suggesting that functional compensation had occurred, and concurred with patient reports of gradually improving equilibrium. This finding is consistent with research completed by Pyykko and colleagues (1994). These authors reported increased postural sway or instability following gentamicin injection, with average postural stability returning to pretreatment levels approximately 2 years after aminoglycoside use. Vestibular rehabilitation may quicken this adaptation process. ecall that patient A demonstrated falls on posturography subtests 5 and 6 at the first post-gentamicin examination; posturography performance was normal 1 month later. Patient A had been referred to physical therapy for vestibular rehabilitation in February 1994 and had been actively participating in a home therapy program since that time. otary chair testing revealed abnormal or borderline normal low-frequency gain following gentamicin use. This finding implies bilateral vestibular impairment with residual vestibular function only measurable at higher frequencies of stimulation. The demonstration of a bilateral weakness was particularly consistent with patient As history. ecall that patient A had a history of old Meniere's in the left ear ; the application of gentamicin was intended to produce a change in the vestibular function of the right ear. Bilateral impairment also concurred with his reports of imbalance and oscillopsia. Both patients demonstrated improved function on rotary chair testing at the second post-treatment evaluation. ow-frequency gain was somewhat improved for patient B. Patient A, however, demonstrated a recovery of gain; only phase was abnormal at 0.01 Hz. Consistent with this improvement, patient A reported recovery of balance and resolution of oscillopsia. Again, note that this patient was involved in a vestibular rehabilitation program. At the second post-treatment examination, both patients reported relief from vertigo. Since the intratympanic application of gentamicin, patient B had experienced no vertigo. Patient A described only one episode, occurring approximately 4 weeks after gentamicin treatment. However, the duration and intensity of this episode were significantly less than those experienced 269
7 Journal of the American Academy of Audiology/Volume 6, Number 3, May 1995 previously. Perception of the vertigo had also changed from a true "spinning" to a "swinging pendulum" sensation. Changes in pure-tone threshold measurements were minimal in the gentamicintreated ears. Patient A demonstrated a 15-dB H threshold improvement at 1000 Hz and a 15-dB threshold decrement at 8000 Hz in the right ear. Patient B experienced a threshold decrement of 20 db at 2000 Hz in the left ear (see Figs. 1 and 2). However, patient B also demonstrated a significant change in word recognition ability. ecall that patient B reported that he was deaf in this ear subsequent to the aminoglycoside injection. Without continued audiologic monitoring, it is difficult to determine if this decrement in word recognition ability is a result of cochleotoxicity or a function of the hearing fluctuations that characterize Meniere's disease. CONCUSION ike labyrinthectomy and vestibular neurectomy, relief from vertigo following intra- tympanic gentamicin use has been achieved in up to 90 percent of reported cases (Beck, 1986 ; Bagger-Sjoback et al, 1990 ; aitakari, 1990 ; Nedzelski et al, 1992). Intratympanic gentamicin application may represent a less invasive alternative to surgically ablative procedures but with similar potential for relief from vertigo. Issues that remain regarding the use of this aminoglycoside in the treatment of Meniere's disease include : 1. The long-term effectiveness of this treatment or the permanency of change to the peripheral vestibular mechanism, as determined by caloric testing ; 2. The minimal effective dosage required to ensure vertigo relief while preserving hearing and avoiding ataxia ; 3. Administration of the aminoglycoside, that is, one injection or a series of injections over several days ; and 4. The effect on hearing, as documented by audiometric testing. esolution of these issues will require the development of longitudinal studies that serially monitor audiometric and vestibular testing over an extended period. Indeed, revised AAOO guidelines recommend follow-up over a 24-month period (Pearson and Brackmann, 1985). Such studies are needed to evaluate the use of intratympanic gentamicin as an alternative in the battery of treatments for Meniere's disease. Acknowledgment. We thank Terri Pratt, M.A. for her assistance with the audiologic evaluations and our colleagues at Mayo Clinic who reviewed earlier versions of this manuscript. EFEENCES Arslan M. (1978). Anew hypothesis on the plurifocal etiology of Meniere's disease. Acta Otolaryngol Suppl (Stockh) 357 :1-19. Bagger-Sjoback D, Bergenius J, undberg AM. (1990). Inner ear effects of topical gentamycin treatment in patients with Meniere's disease. Am J Otol 11 : Beck C. (1986). Intratympanic application of gentamicin for treatment of Meniere's disease. Keio J Med 35 : Beck C, Schmidt C. (1978). Ten years of experience with intratympanically applied streptomycin (gentamycin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 221: Cody DT. (1969). The tack operation for endolymphatic hydrops. aryngoscope 79: Cody DT. (1973). The tack operation. Arch Otolaryngol 97 : Cody DT, McDonald TJ. (1983). Tack operation for idiopathic endolymphatic hydrops : an update. aryngoscope 93 : aitakari K. (1990). Intratympanic gentamycin in severe Meniere's disease. Clin Otolaryngol 15 : Magnusson M, Padoan S. (1991). Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Acta Otolaryngol (Stockh) 111 : Nedzelski JM, Bryce GE, PfleidererAG. (1992). Treatment of Meniere's disease with topical gentamicin : a preliminary report. J Otolaryngol 21: Nedzelski JM, Chiang CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG. (1993). Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease : update of an ongoing study. Am J Otol 14 : Pearson BW, Brackmann DE. (1985). Committee on hearing and equilibrium guidelines for reporting treatment results in Meniere's disease. Otolaryngol Head Neck Surg 93 : Pyykko I, Ishizaki H, Kaasinen S, Aalto H. (1994). Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg 110: uckenstein MJ, utka JA, Hawke M. (1991). The treatment of Meniere's disease : Torok revisited. aryngoscope 101: Schuknecht HF. (1957). Ablation therapy in the management of Meniere's disease. Acta Otolaryngol Suppl (Stockh) 132 :1-42. Torok N. (1977). Old and new in Meniere's disease. aryngoscope 87:
Intratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears
Intratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears Paul W. Bauer, MD, C. Bruce MacDonald, MD, and L. Clarke Cox, PhD Purpose: Intratympanic ototoxic agents have become a widely accepted
More informationDelayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss
Delayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss Tamio Kamei 1, MD, PhD and Kenji Watanabe 2, MD 1 Professor emeritus at Gunma University, Japan 2
More information15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare
15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare MR Imaging of inner ear endo-perilymphatic spaces at 3T after intratympanic contrast agent administration in Definite
More informationMeniere s disease and Sudden Sensorineural Hearing Loss
Meniere s disease and Sudden Sensorineural Hearing Loss Tsutomu Nakashima 1,2 1 Ichinomiya Medical Treatment & Habilitation Center, Ichinomiya, Japan 2 Department of Otorhinolaryngology, Nagoya University,
More informationIntratympanic application of gentamicin for treatment of
Keio Journal of Medicine 35: 36-41, 1986 Lecture Intratympanic application of gentamicin for treatment of Meniere's disease Chlodwig Beck Department of Otolaryngology, Freiburg University Killianstr. 5.
More informationWhat is Meniere's disease? What causes Meniere's disease?
NIH Publication No 95-3403 November 1994 What is Meniere's disease? Meniere's disease is an abnormality of the inner ear causing a host of symptoms, including vertigo or severe dizziness, tinnitus or a
More informationMÉNIÈRE S DISEASE (MD)
Progression of Symptoms of Dizziness in Ménière s Disease Mari Havia, MD; Erna Kentala, MD, PhD ORIGINAL ARTICLE Objective: To evaluate the progression of symptoms of dizziness in Ménière s disease (MD)
More informationNormal membranous labyrinth. Dilated membranous labyrinth in Meniere's disease (Hydrops)
Meniere s Disease Normal membranous labyrinth Dilated membranous labyrinth in Meniere's disease (Hydrops) Normal membranous labyrinth Dilated membranous labyrinth in Meniere's disease (Hydrops) DEFINITION
More informationA patient with endolymphatic hydrops may experience any combination of the below described symptoms:
MENIERE S DISEASE Endolymphatic hydrops and Meniere s disease are disorders of the inner ear. Although the cause is unknown, it probably results from an abnormality of the fluids of the inner ear. In most
More informationEffect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease
Original Article Iranian Journal of Otorhinolaryngology, Vol.26(3), Serial No.76, Jul 2014 Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease Abstract Faramarz
More informationPage: 1 of 6. Transtympanic Micropressure Applications as a Treatment of Meniere's Disease
Page: 1 of 6 Last Review Status/Date: December 2013 as a Treatment of Meniere's Disease Description Transtympanic micropressure treatment for Meniere s disease involves use of a hand-held air pressure
More informationCITY & HACKNEY PATHFINDER CLINICAL COMMISSIONING GROUP. Vertigo. (1) Vertigo. (4) Provisional Diagnosis. (5) Investigations. lasting days or weeks
Authors: Dr Lucy O'Rouke and Mr N Eynon-Lewis Review date: January 2017 Vertigo (1) Vertigo (2) History (3) Examination (4) Provisional Diagnosis (5) Investigations (6) Medical Cause (7) Psychiatric Cause
More informationDIZZINESS Varieties. : Fainting, hypotension : Rotatory, spinning. : Muscular incoordination : Collapse without LOC: ELH : Disturbed awareness
DIZZINESS Varieties head Syncope Vertigo Dysequilibrium Ataxia Drop attacks Confusion Panic Attacks Non-organic : Fainting, hypotension : Rotatory, spinning : Unsteadiness on moving : Muscular incoordination
More informationIntratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss. Original Policy Date
MP 2.01.47 Intratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last
More informationTranstympanic Micropressure Applications as a Treatment of Meniere s Disease
Transtympanic Micropressure Applications as a Treatment of Meniere s Disease Policy Number: 1.01.23 Last Review: 8/2014 Origination: 2/2006 Next Review: 8/2015 Policy Blue Cross and Blue Shield of Kansas
More informationBecause dizziness is an imprecise term, a major role of the clinician is to sort patients out into categories
Dizziness and Imbalance Timothy C. Hain, MD Clinical Professor of Neurology, Otolaryngology, Physical Therapy Chicago Dizziness and Hearing 645 N. Michigan, Suite 410 312-274-0197 Lecture Goals 1. What
More informationUniversity of Groningen. Definition Menière Groningen Mateijsen, Dionisius Jozef Maria
University of Groningen Definition Menière Groningen Mateijsen, Dionisius Jozef Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationSasan Dabiri, MD, Assistant Professor
Sasan Dabiri, MD, Assistant Professor Department of Otorhinolaryngology Head & Neck Surgery Amir A lam hospital Tehran University of Medical Sciences October 2015 Outlines Anatomy of Vestibular System
More informationDrug delivery to the inner ear
Intratympanic Drug Delivery Society of Otorhinolaryngology and Head-Neck Nurses Advantages of intratympanic delivery Higher concentration of drug at site of action Avoid systemic effects May be able to
More informationAcquired Deafness Loss of hearing that occurs or develops sometime in the course of a lifetime, but is not present at birth.
Page 1 of 5 URMC» Audiology Glossary of Terms A Acoustic Neuroma A tumor, usually benign, which develops on the hearing and balance nerves and can cause gradual hearing loss, tinnitus, and dizziness. Acquired
More informationHearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss
THIEME Original Research Hearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss George Psillas 1 Aikaterini Rizou 1 Dimitrios Rachovitsas 1 Gabriel Tsiropoulos 1 Jiannis Constantinidis
More informationCorporate Medical Policy
Corporate Medical Policy Transtympanic Micropressure Applications as a Treatment of File Name: Origination: Last CAP Review: Next CAP Review: Last Review: transtympanic_micropressure_applications_as_a_treatment_of_menieres_disease
More informationMonitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo
Otology & Neurotology 28:798Y800 Ó 2007, Otology & Neurotology, Inc. Monitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo *Maria I. Molina, *Jose A. López-Escámez,
More informationUNILATERAL MENIERE S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT
The Professional Medical Journal DOI: 10.17957/TPMJ/16.3129 ORIGINAL PROF-3129 UNILATERAL MENIERE S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT 1. Professor and Consultant
More informationMenièré s Disease. Overview. Clinical Presentation. Pathology. Intratympanic therapy. Mitchell Ramsey, MD Tripler Army Medical Center
Menièré s Disease Mitchell Ramsey, MD Tripler Army Medical Center Overview Clinical Presentation Pathology Intratympanic therapy Clinical Manifestations Classical type (1861) Vertigo, hearing loss, tinnitus,
More informationTranstympanic Micropressure Applications as a Treatment of Meniere s Disease
Transtympanic Micropressure Applications as a Treatment of Meniere s Disease Policy Number: 1.01.23 Last Review: 8/2017 Origination: 2/2006 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas
More informationIntratympanic Gentamicin for Intractable Ménière s Disease A Review and Analysis of Audiovestibular Impact
190 Update Article THIEME Intratympanic Gentamicin for Intractable Ménière s Disease A Review and Analysis of Audiovestibular Impact Sertaç Yetişer 1 1 Department of Otorhinolaryngology, Anadolu Saglik
More informationClinical Indicators Useful in Predicting Response to the Medical Management of Meniere s Disease
The Laryngoscope Lippincott Williams & Wilkins, Inc., Philadelphia 2000 The American Laryngological, Rhinological and Otological Society, Inc. Clinical Indicators Useful in Predicting Response to the Medical
More informationJ.P.S. Bakshi Manual of Ear, Nose and Throat
J.P.S. Bakshi Manual of Ear, Nose and Throat Reading excerpt Manual of Ear, Nose and Throat of J.P.S. Bakshi Publisher: B. Jain http://www.narayana-publishers.com/b5603 Copying excerpts is not permitted.
More informationClinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo
Original Article Clinical and Experimental Otorhinolaryngology Vol. 11, No. 2: 96-101, June 2018 https://doi.org/10.21053/ceo.2017.00948 pissn 1976-8710 eissn 2005-0720 Clinical Characteristics and Short-term
More informationG. Doobe, 1 A. Ernst, 1 R. Ramalingam, 2 P. Mittmann, 1 and I. Todt Introduction. 2. Materials and Methods
BioMed Research International Volume 2015, Article ID 457318, 4 pages http://dx.doi.org/10.1155/2015/457318 Research Article Simultaneous Labyrinthectomy and Cochlear Implantation for Patients with Single-Sided
More informationIntratympanic therapy of inner ear disease
Intratympanic therapy of inner ear disease Jack J. Wazen, M.D.FACS. VP & Director of Research Silverstein Institute Ear Research Foundation Sudden Sensorineural Definition Hearing Loss Sudden SNHL is defined
More informationControl of eye movement
Control of eye movement Third Nerve Palsy Eye down and out Trochlear Nerve Palsy Note: Right eye Instead of intorsion and depression action of superior oblique See extorsion and elevation Observe how
More informationHearing fluctuation is not a predictor of vertigo attacks in Meniere s syndrome
52 Celene Mc Neill MA 1,2 William Gibson MD 3,4 Alan Taylor PhD 2 Hearing fluctuation is not a predictor of vertigo attacks in Meniere s syndrome Abstract 1 Healthy Hearing & Balnace Care, Sydney, Australia.
More informationVertigo. Definition. Causes. (Dizziness) Benign Paroxysmal Positional Vertigo (BPPV) Labyrinthitis. by Karen Schroeder, MS, RD
Vertigo (Dizziness) by Karen Schroeder, MS, RD En Español (Spanish Version) Definition Vertigo is a feeling of spinning or whirling when you are not moving. It can also be an exaggerated feeling of motion
More informationVESTIBULAR FUNCTION TESTING
VESTIBULAR FUNCTION TESTING Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
More informationSudden Sensorineural Hearing Loss; Prognostic Factors
Original Article Iranian Journal of Otorhinolaryngology, Vol.27(5), Serial No.82, Sep 2015 Abstract Sudden Sensorineural Hearing Loss; Prognostic Factors Dass Arjun 1, * Goel Neha 1, Singhal Surinder K
More informationPeripheral vestibular disorders will affect 1 of 13 people in their lifetime
Peripheral vestibular disorders will affect 1 of 13 people in their lifetime 80% of affected persons seek medical consultation Unclear how many of these are for peripheral vs central disorders Generally:
More informationLearning Objectives. Bilateral Vestibular Loss. Bilateral Vestibular Loss. Diagnosis of vestibulotoxicity is usually easy
Learning Objectives Bilateral Vestibular Loss Learn how to recognize bilateral vestibular loss Learn treatment of bilateral vestibular loss Timothy C. Hain, M.D. Northwestern University Medical School
More informationCochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study
Otology & Neurotology xx:xx xx ß 2016, Otology & Neurotology, Inc. Cochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study Celene McNeill and Kate Eykamp Healthy Hearing and Balance Care,
More informationHearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation
The Laryngoscope VC 2015 The American Laryngological, Rhinological and Otological Society, Inc. Hearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation
More informationmet het oog op evenwicht
met het oog op evenwicht Herman Kingma, Department of ORL, Maastricht University Medical Centre Faculty of Biomedical Technology, Technical University Eindhoven problems in patients with dizziness and
More informationA review of the otological aspects of whiplash injury. Journal of Forensic and Legal Medicine Volume 16, Issue 2, February 2009, Pages 53-55
A review of the otological aspects of whiplash injury 1 Journal of Forensic and Legal Medicine Volume 16, Issue 2, February 2009, Pages 53-55 R.M.D. Tranter and J.R. Graham FROM ABSTRACT Approximately
More informationBenign Paroxysmal Positional Vertigo (BPPV) Structures of importance. The ear is an inertial navigation device. Vestibular Reflexes
Otologic Dizziness (Dizziness from Ear) Structures of importance Timothy C. Hain, MD Northwestern University, Chicago t-hain@northwestern.edu The ear is an inertial navigation device Semicircular Canals
More informationWhat could be reffered to as dizziness by the patient?
What could be reffered to as dizziness by the patient? Rotational vertigo Sense of instability Ataxia of gait Disturbance of vision Loss of contact with surroundings Nausea Loss of memory Loss of confidence
More informationUNILATERAL SUDDEN SENSORINEURAL HEARING LOSS AFTER GENERAL ANESTHESIA
UNILATERAL SUDDEN SENSORINEURAL HEARING LOSS AFTER GENERAL ANESTHESIA Hakan Emirkadi, MD Department of Anesthesiology Golcuk Military Hospital Kocaeli / TURKEY Background-Sudden Sensorineural Hearing Loss
More informationAssisting in Otolaryngology
Assisting in Otolaryngology Learning Objectives Identify the structures and explain the functions of the external, middle, and internal ear. Describe the conditions that can lead to hearing loss, including
More informationUNDERSTANDING VERTIGO
Backgrounder UNDERSTANDING VERTIGO Vertigo is a false sensation of movement, either of one s self or one s surroundings. It may exist as an isolated symptom or it may be associated with other conditions
More informationVestibular testing: what patients can expect
American Hearing Research Foundation Symposium on Dizziness & Balance Disorders April 6, 2013 Vestibular testing: what patients can expect Marcello Cherchi, MD PhD Assistant Professor of Neurology Northwestern
More informationINTRATYMPANIC GENTAMICIN PERFUSIONS. ENDOLYMPHATIC HYDROPS (ELH, Meniere s disease)
INTRATYMPANIC GENTAMICIN PERFUSIONS ENDOLYMPHATIC HYDROPS (ELH, Meniere s disease) Risks, Complications and Post-operative Instructions The inner ear comprises a bony casing (the otic capsule), containing
More informationVertigo: A practical approach to diagnosis and treatment. John Waterston
Vertigo: A practical approach to diagnosis and treatment John Waterston Background. Vertigo is a symptom that has diverse causes. The diagnosis may remain elusive even after exhaustive clinical enquiry
More informationAssessment of Hearing Level after Resolution of Acute Otitis Media. Ali Maeed Al-shehri*
Bahrain Medical Bulletin, Vol. 32, No. 4, December 2010 Assessment of Hearing Level after Resolution of Acute Otitis Media Ali Maeed Al-shehri* Background: Acute otitis media is a very common global bacterial
More informationOtologic (Ear) Dizziness Fistula SCD Bilateral. Other. Neuritis BPPV. Menieres
Otologic Dizziness (Dizziness from Ear) Ear Structures of importance Timothy C. Hain, MD Northwestern University, Chicago t-hain@northwestern.edu The ear is an inertial navigation device Semicircular Canals
More informationVestibular Differential Diagnosis
Vestibular Differential Diagnosis P R E S E N T E D B Y : S H A R I K I C K E R, P T, M P T C E R T I F I C A T E I N V E S T I B U L A R R E H A B I L I T A T I O N 2 0 1 7 L A C E Y H A L E, P T, D P
More informationVertigo. Tunde Magyar MD, PhD
Vertigo Tunde Magyar MD, PhD What could be reffered to as dizziness by the patient? Rotational vertigo Sense of instability Ataxia of gait Disturbance of vision Loss of contact with surroundings Nausea
More informationUpdate '08: Vestibular and Balance Rehabilitation Therapy
Update '08: Vestibular and Balance Rehabilitation Therapy In Context with Surgery Medicine & Diet Symptoms of Dizziness Dizziness non-specific term; encompasses any and all of the specific symptoms: Vertigo
More informationLong-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery
International Tinnitus Journal, Vol. 10, No.2, 197-201 (2004) Long-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery Pollyanna G. Sobrinho, Carlos A. Oliveira, and Alessandra
More informationManagement of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future
Management of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future George W. Hicks, M,D. 7440 N. Shadeland Avenue, Suite 150 Indianapolis, IN 46250 904 N. Samuel Moore Parkway Mooresville, IN
More informationORIGINAL ARTICLE. Short Tone Burst Evoked Myogenic Potentials
OGN TCE Short Tone urst Evoked on the Sternocleidomastoid Muscle re These lso of Vestibular Origin? Toshihisa Murofushi, MD; Masaki Matsuzaki, MD; Chih-Hsiu Wu, MD Objectives: To show that short tone bursts
More informationClinical Characteristics of Labyrinthine Concussion
online ML Comm ORIGINAL ARTICLE Korean J Audiol 2013;17:13-17 pissn 2092-9862 / eissn 2093-3797 http://dx.doi.org/10.7874/kja.2013.17.1.13 Clinical Characteristics of Labyrinthine Concussion Mi Suk Choi,
More informationLabyrinthitis and Vestibular Neuritis
Labyrinthitis and Vestibular Neuritis http://www.patient.co.uk/health/labyrinthitis-and-vestibular-neuritis.htm Labyrinthitis and vestibular neuritis are most commonly caused by a viral infection that
More informationDizziness: Neurological Aspect
Dizziness: Neurological Aspect..! E-mail: somtia@kku.ac.th http://epilepsy.kku.ac.th Features between peripheral and central vertigo 1. Peripheral Central 2.! " # $ " Imbalance Mild-moderate Severe 3.!
More informationLabyrinth Anesthesia A Forgotten but Practical Treatment Option in Ménière s Disease
Original Paper ORL 2003;65:84 90 DOI: 10.1159/000070771 Received: February 20, 2003 Accepted: March 6, 2003 Labyrinth Anesthesia A Forgotten but Practical Treatment Option in Ménière s Disease Oliver Adunka
More informationRelieve your vertigo symptoms with a simple and effective treatment for Ménière s disease
Relieve your vertigo symptoms with a simple and effective treatment for Ménière s disease Ménière s Disease Ménière s disease is a complex inner ear condition that can be unpredictable and disabling. Usually
More informationVery few dizzy conditions have a surgical treatment SURGICAL MANAGEMENT OF THE DIZZY PATIENT. Surgical Treatments for. Shunts and Sac Surgery
SURGICAL MANAGEMENT OF THE DIZZY PATIENT Very few dizzy conditions have a surgical treatment Timothy C. Hain, M.D. Meniere s Disease Perilymphatic Fistula (PLF) Superior Canal Dehiscence (SSD) Benign Paroxysmal
More informationVertigo. Definition Important history questions Examination Common vertigo cases and management Summary
Vertigo Vertigo Definition Important history questions Examination Common vertigo cases and management Summary Cases 1) 46 year old man presents two weeks after knocking his head with recurrent episodes
More information'PREHAB': Vestibular prehabilitation to ameliorate the effect of a sudden vestibular loss.
'PREHAB': Vestibular prehabilitation to ameliorate the effect of a sudden vestibular loss. Magnusson, Måns; Karlberg, Mikael; Tjernström, Fredrik Published in: NeuroRehabilitation DOI: 10.3233/NRE-2011-0689
More informationSudden sensorineural hearing loss (SSNHL) is defined
Transtympanic steroids for treatment of sudden hearing loss GERARD J. GIANOLI, MD, FACS, and JOHN C. LI, MD, FACS, Baton Rouge, Louisiana, and Jupiter, Florida OBJECTIVES: To determine whether transtympanic
More informationAcoustic neuroma s/p removal BPPV (Crystals)- 50% of people over 65 y/ o with dizziness will have this as main reason for dizziness
Dizziness and the Heart Mended Hearts Inservice Karen Hansen, PT, DPT, Cert Vestibular Rehab, CEAS Tennessee Therapy & Balance Center, LLC July 21, 2016 Balance We maintain balance with input from our
More informationVERTIGO. Tuesday 20 th February 2018 Dr Rukhsana Hussain. Disclaimers apply:
VERTIGO Tuesday 20 th February 2018 Dr Rukhsana Hussain WHAT IS VERTIGO? 4 Vertigo is defined as an illusory sensation of motion of either the self or the surroundings in the absence of true motion. Explaining
More informationfunctiestoornissen van het evenwichtssysteem: een wereld van onbegrip
functiestoornissen van het evenwichtssysteem: een wereld van onbegrip Herman Kingma, department of ORL, Maastricht University Medical Centre Maastricht Research Institute Mental Health and Neuroscience
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: vestibular_function_testing 5/2017 N/A 10/2017 5/2017 Description of Procedure or Service Dizziness, vertigo,
More informationTEMPLATES FOR COMPREHENSIVE BALANCE EVALUATION REPORTS. David Domoracki PhD Cleveland Louis Stokes VA Medical Center
TEMPLATES FOR COMPREHENSIVE BALANCE EVALUATION REPORTS David Domoracki PhD Cleveland Louis Stokes VA Medical Center The following templates are in outline form. I designed them so that the IRM local network
More informationSECONDARY ENDOLYMPHATIC HYDROPS
SECONDARY ENDOLYMPHATIC HYDROPS By Susan Pesznecker, RN, with the Vestibular Disorders Association. Updates by Jeremy Hinton, DPT. Endolymphatic hydrops is a disorder of the inner ear and can affect the
More informationClinically applicable objective diagnosis of Ménière's disease by MR: How "to do" it
Clinically applicable objective diagnosis of Ménière's disease by MR: How "to do" it Poster No.: C-0488 Congress: ECR 2013 Type: Authors: Keywords: DOI: Educational Exhibit S. Naganawa, M. Yamazaki, H.
More informationStudy on Hearing Status of Elderly Patients attending a Specialized ENT Hospital (SAHIC)
Bangladesh J Otorhinolaryngol 2015; 21(2): 80-84 Original Article Study on Hearing Status of Elderly Patients attending a Specialized ENT Hospital (SAHIC) Mohammad Wakilur Rahman 1, Ali Imam Ahasan 2,
More informationCochlear Implant, Bone Anchored Hearing Aids, and Auditory Brainstem Implant
Origination: 06/23/08 Revised: 10/15/16 Annual Review: 11/10/16 Purpose: To provide cochlear implant, bone anchored hearing aids, and auditory brainstem implant guidelines for the Medical Department staff
More informationVestibular Migraine Panel Session. Panelists. Learner Objectives 7/31/2017. Steven Harvey MD. Fallon Schloemer MD.
Vestibular Migraine Panel Session David R. Friedland MD, PhD Professor and Vice-Chair Chief, Division of Otology and Neuro- Otologic Skull Base Surgery Panelists Steven Harvey MD Neuro-otologist Fallon
More informationP0 Antigen Detection in Sudden Hearing Loss and Ménière s Disease: A New Diagnostic Marker?
Acta Otolaryngol 2004; 124: 1145/1148 P0 Antigen Detection in Sudden Hearing Loss and Ménière s Disease: A New Diagnostic Marker? DESIDERIO PASSALI 1, VALERIO DAMIANI 1, RENZO MORA 2, FRANCESCO MARIA PASSALI
More informationFukuda Stepping Test: Sensitivity and Specificity
Fukuda Stepping Test: Sensitivity and Specificity Julie A. Honaker University of Nebraska at Lincoln, jhonaker2@unl.edu Neil T. Shepard Mayo Clinic, shepard.neil@mayo.edu Includes Fukuda Stepping Test
More informationDRUG-INDUCED HEARING IMPAIRMENTS
DRUG-INDUCED HEARING IMPAIRMENTS Datten Bangun & Yunita S.Pane Dept Farmakologi & Therapetik Fakultas Kedokteran USU M E D A N Ototoxicity; Stedman s Medical Dictionary: ototoxicity is property of being
More information1.0 ANCC CONTACT HOUR. Navigating the challenges of. Meniere disease. By Richard L. Pullen, Jr., EdD, MSN, RN, CMSRN
1.0 ANCC CONTACT HOUR Navigating the challenges of Meniere disease By Richard L. Pullen, Jr., EdD, MSN, RN, CMSRN AN ESTIMATED 10 to 150 per 100,000 persons have Meniere disease (MD). 1 Various organizations
More informationSubject: Vestibular Rehabilitation
01-92502-14 Original Effective Date: 06/15/05 Reviewed: 09/27/18 Revised: 10/15/18 Subject: Vestibular Rehabilitation THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION
More informationICD10 CODES CODE DESCRIPTION R Abnormal auditory function study H Abnormal auditory perception, bilateral H Abnormal auditory
ICD10 CODES CODE DESCRIPTION R94.120 Abnormal auditory function study H93.293 Abnormal auditory perception, bilateral H93.292 Abnormal auditory perception, left ear H93.291 Abnormal auditory perception,
More informationHearing in Patients Operated Unilaterally for Otosclerosis. Self-assessment of Hearing and Audiometric Results
Acta Otolaryngol (Stockh) 1999; 119: 453 458 Hearing in Patients Operated Unilaterally for Otosclerosis. Self-assessment of Hearing and Audiometric Results LARS LUNDMAN 1, LENNART MENDEL 1, DAN BAGGER-SJO
More informationORIGINAL ARTICLE. A New Physical Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo
ORIGINAL ARTICLE Victor Vital, MD; Athanasia Printza, MD; Joseph Vital, MD; Stefanos Triaridis, MD; Miltiadis Tsalighopoulos, MD From the Department of Otolaryngology, Aristotle University of Thessaloniki,
More informationAudiogram. Assistant Professor King Saud University Otolaryngology Consultant Otologist, Neurotologist & Skull Base Surgeon King Abdulaziz Hospital
Audiogram Dr. Abdulrahman Hagr MBBS FRCS(c) Assistant Professor King Saud University Otolaryngology Consultant Otologist, Neurotologist & Skull Base Surgeon King Abdulaziz Hospital Purpose of Audiogram
More informationPublic Statement: Medical Policy Statement:
Medical Policy Title: Implantable Bone ARBenefits Approval: 09/28/2011 Conduction Hearing Aids Effective Date: 01/01/2012 Document: ARB0190 Revision Date: Code(s): 69714 Implantation, osseointegrated implant,
More informationThe Dizzy Patient: How You Can Help
MICHAEL J. RUCKENSTEIN, MD, MSc, FACS University of Pennsylvania LINDSAY A. GOODSTEIN University of Maryland The Dizzy Patient: Dr Ruckenstein is professor of otorhinolaryngology, head and neck surgery,
More informationVestibular-Evoked Myogenic Potentials as a Test of Otolith Function
Original Paper Med Principles Pract 2002;11:136 140 Received: April 10, 2001 Accepted: March 17, 2002 Vestibular-Evoked Myogenic Potentials as a Test of Otolith Function Khalid Al-Sebeih a Anthony Zeitouni
More information2/8/2017 WHERE ARE WE? East Amherst East Aurora Hamburg West Seneca Williamsville Boulevard
2/8/2017 WHERE ARE WE? East Amherst East Aurora Hamburg West Seneca Williamsville Boulevard 1 2/8/2017 MY GOAL TODAY. 1. Provide a quick overview on falls 2. How our balance systems work 3. What treatments
More informationVIDEONYSTAGMOGRAPHY (VNG) TUTORIAL
VIDEONYSTAGMOGRAPHY (VNG) TUTORIAL Expected Outcomes Site of lesion localization: Determine which sensory input, motor output, and/or neural pathways may be responsible for the patient s reported symptoms
More informationClinical outcomes with betahistine in vestibular disorders
Clinical outcomes with betahistine in vestibular disorders Michael Strupp MD, FRCP, FANA, FEAN Department of Neurology, German Center for Vertigo and Balance Disorders University of Munich Role of betahistine
More informationInner Ear Disorders. Information for patients and families
Inner Ear Disorders Information for patients and families Read this booklet to learn about: What are inner ear disorders Symptoms Tests you may need Treatment options Please visit the UHN Patient Education
More informationA&P 1. Ear, Hearing & Equilibrium Lab. Basic Concepts. Pre-lab Exercises
A&P 1 Ear, Hearing & Equilibrium Lab Basic Concepts Pre-lab Exercises In this "Lab Exercise Guide", we will be looking at the basics of hearing and equilibrium. NOTE: these notes do not follow the order
More informationVertigo. Done by : Njoud Alrasheed. Reviewed by :Hadeel B. Alsulami. Correction File
Vertigo Objectives: To know anatomy of balance organs Physiology of balance Relevant history in dizzy patients Classification of vertigo Common peripheral causes of vertigo, clinical features, investigation
More informationVestibular physiology
Vestibular physiology 2017 Utricle A flat epithelium: horizontal in the upright head Utricle Hair cells: no axons hair cells Utricle Hair cells synapse onto 8th nerve afferents. 8th nerve afferents Hair
More informationMs Melissa Babbage. Senior Audiologist Clinic Manager Dilworth Hearing
Ms Melissa Babbage Senior Audiologist Clinic Manager Dilworth Hearing 14:00-14:55 WS #30: Sudden Sensorineural Hearing Loss and Management of Single Sided Deafness 15:05-16:00 WS #40: Sudden Sensorineural
More informationStudy of brainstem evoked response audiometry in sensorineural hearing deafness- A hospital based study
Original Research Article Study of brainstem evoked response audiometry in sensorineural hearing deafness- A hospital based study Swapnil Gosavi 1,*, James Thomas 2, G.D. Mahajan 3 1 Lecturer, MGM Medical
More information